Neurorehabilitation on Upper Limb and on Fatigue in Multiple Sclerosis
Effects of Neurorehabilitation on Upper Limb Performance and on Fatigue in People With Multiple Sclerosis
1 other identifier
interventional
20
1 country
1
Brief Summary
In Multiple Sclerosis the multiplicity of physical and psychological dysfunctions have been shown to exhibit a number of life-altering problems such as fatigue, limb weakness, alteration of upper extremity fine motor coordination, loss of sensation, spasticity. These problems affect performance of many daily living activities (ADL) such as dressing, bathing, self-care, and writing, thus reducing functional independence and self-rated quality of life. Twenty people with Multiple Sclerosis will receive neurorehabilitation treatment comprising a combination of aerobic training and upper limb task-oriented training. The aim of this pilot crossover study is to evaluate the effects of neurorehabilitation on upper limb performance and on fatigue in People with Multiple Sclerosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 8, 2016
CompletedFirst Posted
Study publicly available on registry
November 10, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedNovember 11, 2016
November 1, 2016
1.1 years
November 8, 2016
November 10, 2016
Conditions
Outcome Measures
Primary Outcomes (2)
Change from Baseline in 9-hole peg test at 2 and 4 months
baseline, then participants were followed for the duration the outpatient treatment protocol, an average of 8 weeks, and at follow up 2 months after the end of the treatment protocol
Change from Baseline in Heart Rate at 2 and 4 months
baseline, then participants were followed for the duration the outpatient treatment protocol, an average of 8 weeks, and at follow up 2 months after the end of the treatment protocol
Study Arms (2)
Neurorehabilitation
EXPERIMENTALParticipants in the experimental group will receive 1 hour treatment comprising 30' of aerobic training on an ergometer and 30' of task-oriented training focused on uppper limb rehabilitation.
Baseline
NO INTERVENTIONNo intervention is planned
Interventions
Participants in the experimental group will receive 1 hour treatment comprising 30' of aerobic training and 30' of task-oriented training focused on uppper limb rehabilitation for 3 times a week for 20 sessions.
Eligibility Criteria
You may qualify if:
- Diagnosis of Multiple Sclerosis
- no relapses in the last three months
- Expanded Disability Status Scale (EDSS) ≤ 8;
You may not qualify if:
- subjects with relapses
- worsening of the pathology in the last three months
- subjects with cognitive and psychiatric disturbances
- subjects with cardiovascular disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fondazione Don Carlo Gnocchi Onluslead
- University of Genovacollaborator
Study Sites (1)
Fondazione Don Gnocchi ONLUS
Milan, 20148, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 8, 2016
First Posted
November 10, 2016
Study Start
November 1, 2016
Primary Completion
December 1, 2017
Last Updated
November 11, 2016
Record last verified: 2016-11